At a glance
- Originator Arch Chemicals
- Class Antimalarials; Pyridines; Small molecules; Thiones
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 12 Dec 2003 No development reported - Preclinical for Malaria in USA (unspecified route)
- 26 Sep 2000 Preclinical development for Malaria in USA (Unknown route)